198 related articles for article (PubMed ID: 10641447)
21. Hepatitis B virus blood screening: unfinished agendas.
Comanor L; Holland P
Vox Sang; 2006 Jul; 91(1):1-12. PubMed ID: 16756595
[TBL] [Abstract][Full Text] [Related]
22. [Progresses in the molecular diagnosis of hepatitis B viral infection].
Panait M; Oprişan G; Codiţă I
Bacteriol Virusol Parazitol Epidemiol; 2008; 53(1):5-12. PubMed ID: 19241991
[No Abstract] [Full Text] [Related]
23. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
Yoshikawa A; Gotanda Y; Minegishi K; Taira R; Hino S; Tadokoro K; Ohnuma H; Miyakawa K; Tachibana K; Mizoguchi H;
Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
[TBL] [Abstract][Full Text] [Related]
24. Seroepidemiology of hepatitis B virus markers among hospital health care workers. Analysis of certain potential risk factors.
Daw MA; Siala IM; Warfalli MM; Muftah MI
Saudi Med J; 2000 Dec; 21(12):1157-60. PubMed ID: 11360090
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of posttransfusion hepatitis B virus infection.
Wang D; Tan D; Cao X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):77-9. PubMed ID: 11503032
[TBL] [Abstract][Full Text] [Related]
26. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
27. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
28. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan.
Liu CJ; Lo SC; Kao JH; Tseng PT; Lai MY; Ni YH; Yeh SH; Chen PJ; Chen DS
J Hepatol; 2006 Jan; 44(1):39-46. PubMed ID: 16168517
[TBL] [Abstract][Full Text] [Related]
29. HBV and HCV infection in Japanese dental care workers.
Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
[TBL] [Abstract][Full Text] [Related]
30. [Dynamics of HBV-DNA level in acute hepatitis B].
Zhao H; Cao JH; Tian GS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):159-61. PubMed ID: 12870000
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between the immunohistopathological changes of hepatitis B virus carrier mothers' placentas and fetal hepatitis B virus infection].
Liu Y; Zhang J; Zhang R; Li S; Kuang J; Chen M; Liu X
Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):278-80. PubMed ID: 12133400
[TBL] [Abstract][Full Text] [Related]
32. Detection of hepatitis B virus deoxyribonucleic acid using real-time polymerase chain reaction method in pooled-plasma samples of Turkish blood donors.
Karakoc AE; Berkem R; Beyaz E
Clin Lab; 2009; 55(5-6):229-34. PubMed ID: 19728557
[TBL] [Abstract][Full Text] [Related]
33. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors.
Allain JP; Sarkodie F; Candotti D; Opare-Sem O
Transfusion; 2005 Jun; 45(6):1039-40. PubMed ID: 15935007
[No Abstract] [Full Text] [Related]
34. Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver.
Ciesek S; Helfritz FA; Lehmann U; Becker T; Strassburg CP; Neipp M; Ciner A; Fytili P; Tillmann HL; Manns MP; Wedemeyer H
J Infect Dis; 2008 Feb; 197(3):355-60. PubMed ID: 18248299
[TBL] [Abstract][Full Text] [Related]
35. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of two rapid hepatitis B surface antigen detection tests for screening in a blood bank.
Verstraeten T; Keya A
East Afr Med J; 1997 Nov; 74(11):717-8. PubMed ID: 9557444
[TBL] [Abstract][Full Text] [Related]
37. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003.
Neau D; Winnock M; Jouvencel AC; Faure M; Castéra L; Legrand E; Lacoste D; Ragnaud JM; Dupon M; Fleury H; Lafon ME; Dabis F;
Clin Infect Dis; 2005 Mar; 40(5):750-3. PubMed ID: 15714424
[TBL] [Abstract][Full Text] [Related]
38. [Investigation of hepatitis B virus infection in blood donors].
Wang D; Liu C; Shen Y; Tan D
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):540-2. PubMed ID: 10806762
[TBL] [Abstract][Full Text] [Related]
39. [Epidemiology of HBV: the trend from 1970 to the present].
Hayashi J; Furusyo N
Nihon Rinsho; 2004 Aug; 62 Suppl 8():180-5. PubMed ID: 15453311
[No Abstract] [Full Text] [Related]
40. Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion.
Inaba S; Ito A; Miyata Y; Ishii H; Kajimoto S; Tanaka M; Maruta A; Saito S; Yugi H; Hino M; Tadokoro K
Transfusion; 2006 Nov; 46(11):2028-9. PubMed ID: 17076860
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
